1 01/02/2023 31/01/2024 2024-01-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2023-02-01 Sage Accounts Production 23.0 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 08858357 2023-02-01 2024-01-31 08858357 2024-01-31 08858357 2023-01-31 08858357 2022-02-01 2023-01-31 08858357 2023-01-31 08858357 2022-01-31 08858357 bus:RegisteredOffice 2023-02-01 2024-01-31 08858357 bus:LeadAgentIfApplicable 2023-02-01 2024-01-31 08858357 bus:Director1 2023-02-01 2024-01-31 08858357 core:WithinOneYear 2024-01-31 08858357 core:WithinOneYear 2023-01-31 08858357 bus:Micro-entities 2023-02-01 2024-01-31 08858357 bus:AuditExemptWithAccountantsReport 2023-02-01 2024-01-31 08858357 bus:SmallCompaniesRegimeForAccounts 2023-02-01 2024-01-31 08858357 bus:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31 08858357 bus:FullAccounts 2023-02-01 2024-01-31
Company registration number: 08858357
RAI CLINICAL DEVELOPMENT LIMITED
Unaudited filleted financial statements
31 January 2024
Robinson Sterling
Business Advisory, Taxation & Strategic Planning Consultants
616D Green Lane
Ilford
Essex IG3 9SE
Tel. No. 020 8598 4130
Fax No. 020 8598 4140
Email: post@robinsonsterling.com
Web: www.robinsonsterling.com
RAI CLINICAL DEVELOPMENT LIMITED
Contents
Directors and other information
Accountants report
Statement of financial position and notes to the financial statements
RAI CLINICAL DEVELOPMENT LIMITED
Directors and other information
Directors Mr Dilpreet Rai
Company number 08858357
Registered office 181 Lodge Lane
Grays
Essex
RM17 5PT
Business address 181 Lodge Lane
Grays
Essex
RM17 5PT
Accountants Robinson Sterling
616D Green Lane
Ilford
Essex
IG3 9SE
Bankers National Westminster Bank PLC
RAI CLINICAL DEVELOPMENT LIMITED
Chartered accountants report to the board of directors on the preparation of the
unaudited statutory financial statements of RAI CLINICAL DEVELOPMENT LIMITED
Year ended 31 January 2024
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of RAI CLINICAL DEVELOPMENT LIMITED for the year ended 31 January 2024 which comprise the statement of financial position and related notes from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com /en/members/regulations-standards-and-guidance/.
This report is made solely to the board of directors of RAI CLINICAL DEVELOPMENT LIMITED, as a body, in accordance with the terms of our engagement letter dated 3 September 2024. Our work has been undertaken solely to prepare for your approval the financial statements of RAI CLINICAL DEVELOPMENT LIMITED and state those matters that we have agreed to state to the board of directors of RAI CLINICAL DEVELOPMENT LIMITED as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than RAI CLINICAL DEVELOPMENT LIMITED and its board of directors as a body for our work or for this report.
It is your duty to ensure that RAI CLINICAL DEVELOPMENT LIMITED has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of RAI CLINICAL DEVELOPMENT LIMITED. You consider that RAI CLINICAL DEVELOPMENT LIMITED is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of RAI CLINICAL DEVELOPMENT LIMITED. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
Robinson Sterling
Chartered Accountants
616D Green Lane
Ilford
Essex
IG3 9SE
3 September 2024
RAI CLINICAL DEVELOPMENT LIMITED
Statement of financial position
31 January 2024
2024 2023
£ £
Fixed assets 1,804 2,122
_______ _______
Current assets 452,104 354,264
Creditors: amounts falling due within one year ( 63,699) ( 48,536)
_______ _______
Net current assets 388,405 305,728
_______ _______
Total assets less current liabilities 390,209 307,850
Accruals and deferred income ( 2,797) ( 1,500)
_______ _______
Net assets 387,412 306,350
_______ _______
Capital and reserves 387,412 306,350
_______ _______
Notes to the financial statements
RAI CLINICAL DEVELOPMENT LIMITED
Year ended 31 January 2024
1. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2023: 1 ).
2. Directors advances, credits and guarantees
There were no directors advances as at the year ended 31 January 2024.
For the year ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 03 September 2024 , and are signed on behalf of the board by:
Mr Dilpreet Rai
Director
Company registration number: 08858357
The company is a private company limited by shares, registered in England and Wales.